i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Presentation of New C5a and Vilobelimab (IFX-1) Data from Phase IIB SHINE Study at the 2021 Virtual European Hidradenitis Suppurativa Foundation Conference

Feb 11, 2021

Time to read 4 Minutes

Download PDF

Back